Nivalin in the treatment of residual post-polio paralysis and pseudo-hypertrophic muscular dystrophy.
D002648:Child; D002675:Child, Preschool; D005158:Facial Paralysis / Q000188:drug therapy*; D005702:Galantamine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D009136:Muscular Dystrophies / Q000188:drug therapy*; D011051:Poliomyelitis / Q000150:complications*
D005702:Galantamine